Implantable continuous glucose monitor moves closer to market with $12M Series C
San Diego startup GlySens says its implantable continuous glucose monitor is in the homestretch: It has a few more developmental tweaks to finish on its diabetes-tracking device, and just closed a $12 million Series C that’ll help get it market-ready. GlySens’ device is meant to work, subcutaneously, for about a year. It’s made up of two parts: […]